Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Ronald Rauch

2PUBLICATIONS
13CO-AUTHORS
NanomaterialsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

Sort by Publication Date:
|Jan 15, 2025
Optimal size and PEG coating of gold nanoparticles for prolonged blood circulation: a statistical analysis of published data.

Dmitry Nevozhay, Ronald Rauch, Zhongya Wang

|Oct 10, 2024
Real-World Immune-Related Adverse Events in Patients With Early Triple-Negative Breast Cancer Who Received Pembrolizumab.

Athira Jayan, Jasmine S Sukumar, Benjamin Fangman

Pageof 1

Frequent Collaborators

1 joint publications

Athira Jayan

1 joint publications

Jasmine S Sukumar

1 joint publications

Benjamin Fangman

1 joint publications

Tejal Patel

1 joint publications

Akshara Singareeka Raghavendra

1 joint publications

Karen Basen-Engquist

1 joint publications

Debasish Tripathy

1 joint publications

Yinghong Wang

1 joint publications

Sonya S Khan

1 joint publications

Carlos H Barcenas

Frequent Collaborators

1 joint publications

Athira Jayan

1 joint publications

Jasmine S Sukumar

1 joint publications

Benjamin Fangman

1 joint publications

Tejal Patel

Top Related Videos

Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery
09:09

Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery

Published on : Jun 23, 2020

6.7K
Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients
07:42

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on : Feb 07, 2021

4.8K
See more related videos

Top Related Videos

Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery
09:09

Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery

Published on : Jun 23, 2020

6.7K
Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients
07:42

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on : Feb 07, 2021

4.8K
See more related videos